Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > WES

WES (Whole Exome Sequencing)

Diagnostic test based on NGS of the complete coding region of all genes of the Human Genome.
Overview
Indications
Applications

Whole Exome Sequencing

Our WES tests have been developed to maximize the diagnostic yield for patients with genetic disorders and include:

  • High-quality sequencing data
  • State-of-the art bioinformatics pipeline
  • High-quality interpretation by rare disease expert team of PhD geneticists
  • Variant classification according to ACMG guidelines
  • High quality population databases curated by experts
  • Improved coverage and clinical sensitivity of challenging genes
  • CNV detection
  • Clinical interpretation and support

Main clinical indications:

  • Complex phenotypes with multiple differential diagnoses
  • Genetically heterogeneous disorders
  • Suspected genetic disorders where a specific genetic test is not available
  • Inconclusive previous genetic testing

Main clinical applications:

  • Preconception: patients and couples with complex or genetically heterogeneous conditions or with a high risk
  • Prenatal: Genetic syndromes, complex phenotypes, or clinical evidences by ultrasonographic findings
  • Abortions or stillbirth with complex phenotypes and polymalformated fetuses
  • Neonate babies and enfants with complex phenotypes, differential diagnoses, genetically heterogeneous disorders, etc
  • Children with developmental or cognitive impairment, intellectual disability, autism, complex phenotypes, genetically heterogeneous disorders, differential diagnoses, etc
  • Adults and couples with complex phenotypes, differential diagnoses, genetically heterogeneous disorders, etc

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information